vTv Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

vTv Therapeutics

16/08/2022 01:44

* vTv Therapeutics Inc  VTVT.OQ  reported a quarterly
adjusted
loss of 4 cents​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 9 cents per share.
    * Revenue held steady 0% to $9.00 thousand from a year ago;
analysts expected zero. 
    * vTv Therapeutics Inc's reported EPS for the quarter was a
loss
of 4 cents​.
    * The mean earnings estimate of analysts had risen by
about 10% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * vTv Therapeutics Inc shares had risen by 72.0% this
quarter and
gained 29.6% so far this year.
    * The company reported a quarterly loss of $3.15 million.
    * Wall Street's median 12-month price target for vTv
Therapeutics
Inc is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 16
at 12:44 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.09          -0.04          Beat
 Mar. 31 2022      -0.08          -0.10          Missed
 Dec. 31 2021      -0.07          -0.11          Missed
 Sep. 30 2021      -0.07          -0.02          Beat